AScalate: Treat-to-target in Axial Spondyloarthritis
Clinical trial NCT03906136 · COMPLETED
Trial details
- NCT number
- NCT03906136
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-04
- Primary completion
- 2022-02-04
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.